The INL – International Iberian Nanotechnology Laboratory and the Regional High Specialty Hospital of the Yucatán Peninsula “HRAEPY”, a decentralised body of the Federal Public Administration within the Mexico Government initiated a cooperation agreement in the field of nanomedicine back in 2020. The aim of this cooperation agreement, signed during a remote ceremony due to the pandemic, was to carry out bilateral clinical research in the field of precision medicine. HRAEPY was created in 2004 to offer highly specialised medical services, with the ability to solve particularly complex medical care problems, of low frequency, but seriously affecting the population of southeast Mexico. The research unit of HRAEPY was officially launched in 2020 by Dr Roberto Lugo, Dr Ana Ligia Gutiérrez, and Dr Azalia Avila-Nava, with the aim of developing basic, applied, and clinical research, focused on the specific needs of the population in the Yucatan peninsula. Now that the laboratories at HRAEPY are fully operational, the researchers of the Medical Devices Research Group at INL, Dr Lorena Diéguez and Paulina Piairo, visited the facilities to prepare the next steps of the collaboration and the launch of clinical research activities in the field of liquid biopsy applied to clinical oncology. Taking […]
Read more
